Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder is a research paper published in JAMA Network Open (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 3P30DA040500-03S1
Health Economics of Substance Use Disorder, HCV, and HIV Treatment in the Era of Integrated Health Care
National Institutes of Health
Grant: 1R01DA046527-01
Researching Effective Strategies to Prevent Opioid Death (RESPOND)
National Institutes of Health
Grant: 5K23DA044085-05
Engaging Young People who Inject Drugs into HCV and HIV Care
National Institutes of Health
Grant: 5K01DA051684-04
Strategies to reduce serious bacterial infections and overdose among people who inject drugs
NIDA NIH HHS
Grant: R01 DA046527
NIDA NIH HHS
Grant: K01 DA051684
NIDA NIH HHS
Grant: P30 DA040500
NIDA NIH HHS
Grant: DP2 DA051864
NIDA NIH HHS
Grant: K23 DA044085
FWCI
4.77
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals